These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10856561)

  • 1. Role of cyclosporine in inducing hyperuricemia in heart transplant patients.
    Sahar G; Stamler A; Berman M; Ben Gal T; Vaturi M; Aravot D; Vidne BA
    Transplant Proc; 2000 Jun; 32(4):729-30. PubMed ID: 10856561
    [No Abstract]   [Full Text] [Related]  

  • 2. Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience.
    Pham SM; Kormos RL; Kawai A; Murali S; Hattler BG; Demetris AJ; Griffith BP
    Transplant Proc; 1996 Apr; 28(2):1002-4. PubMed ID: 8623208
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of cyclosporine monitoring with trough levels to levels obtained 6 hours after the morning dose in heart transplant patients: a prospective randomized study.
    Cantarovich M; Latter D; Fitchett D
    Transplant Proc; 1997; 29(1-2):602-4. PubMed ID: 9123149
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term nephrotoxicity of low doses of cyclosporine in heart transplant recipients.
    Ben Hmida M; Baumelou A; Desruesnnes M; Cabrol A; Pavie A; Grandjbakhch I; Cabrol C
    Transplant Proc; 1995 Oct; 27(5):2725-7. PubMed ID: 7482891
    [No Abstract]   [Full Text] [Related]  

  • 5. Neoral versus Sandimmun: clinical impact and modification of immunosuppressive therapy in cardiac transplantation.
    Maccherini M; Bernazzali S; Diciolla F; Giunti G; Bizzarri F; Lisi GF; Davoli G; Biagioli B; Giomarelli PP; Simeone F; Caciorgna M; Marchetti L; Pula G; Sani G; Toscano M
    Transplant Proc; 1998 Aug; 30(5):1904-5. PubMed ID: 9723327
    [No Abstract]   [Full Text] [Related]  

  • 6. Improvement in correlation between oral dose of cyclosporine and cyclosporinemia after substitution of conventional cyclosporine by Neoral cyclosporine in 296 liver transplant patients.
    Bilbao I; Parrilla P; Rimola A; Figueras J; Fabrega E; Gomez M; De Vicente E; Margarit C
    Transplant Proc; 1998 Aug; 30(5):1833-7. PubMed ID: 9723300
    [No Abstract]   [Full Text] [Related]  

  • 7. Urate oxidase in hyperuricemic heart transplant recipients treated with azathioprine.
    Ippoliti G; Negri M; Campana C; Vigano M
    Transplantation; 1997 May; 63(9):1370-1. PubMed ID: 9158039
    [No Abstract]   [Full Text] [Related]  

  • 8. Kidney function in cyclosporine-treated pediatric heart transplant recipients.
    Laine J; Jalanko H; Leijala M; Sairanen H; Holmberg C
    J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter evaluation of immunosuppressive regimens in heart transplantation. The Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1997; 29(1-2):617-9. PubMed ID: 9123156
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients.
    Teebken OE; Strüber M; Harringer W; Pichlmaier MA; Haverich A
    Transplant Proc; 2002 Jun; 34(4):1265-8. PubMed ID: 12072335
    [No Abstract]   [Full Text] [Related]  

  • 11. Implication of HLA mismatch in the clinical outcome of orthotopic heart transplantation.
    Aziz TM; Sheldon S; el-Gamel A; Krysiak P; Campbell C; Rahman A; Dyer P; Yonan N; Deiraniya A
    Transplant Proc; 1998 Aug; 30(5):1917-9. PubMed ID: 9723332
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of cyclosporine MEPC (Neoral) in heart transplant recipients.
    Fukushima N; Ohtake S; Sawa Y; Nishimura M; Kobayashi Y; Shirakura R; Nakata S; Matsuda H
    Transplant Proc; 1998 Nov; 30(7):3337-8. PubMed ID: 9838473
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical impact of Neoral in heart transplantation.
    Aziz T; el-Gamel A; Keevil B; Martyszczuk R; Campbell C; Rahman A; Deiraniya A; Yonan N
    Transplant Proc; 1998 Jun; 30(4):1152-3. PubMed ID: 9636466
    [No Abstract]   [Full Text] [Related]  

  • 14. Risks and benefits of withdrawing cyclosporine from the long-term immunosuppression regimen of heart and heart-lung transplant recipients.
    Walker S; Habib S; Thompson D; Khaghani A; Yacoub M; Banner N
    Transplant Proc; 1998 Jun; 30(4):1149-51. PubMed ID: 9636465
    [No Abstract]   [Full Text] [Related]  

  • 15. Early cyclosporine blood levels impact the incidence of acute rejection and overall mortality in the first year after heart transplantation.
    Gómez-Sánchez MA; Delgado JF; Escribano P; Santos M; Sotelo T; Gil R; Hernández-Afonso J; Ortuño B; Romero F; Sáenz de la Calzada C; Rodriguez JE; Rufilanchas JJ
    Transplant Proc; 1998 Aug; 30(5):1671-2. PubMed ID: 9723237
    [No Abstract]   [Full Text] [Related]  

  • 16. C(2) monitoring of cyclosporine in stable heart transplant patients after two daily and three daily doses.
    Baraldo M; Francesconi A; Barbone F; Tursi V; Livi U; Furlanut M
    Transplant Proc; 2002 Dec; 34(8):3246-8. PubMed ID: 12493435
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine-based steroid-free therapy in pediatric heart transplantation: long-term results.
    Livi U; Caforio AL; Gambino A; Tursi V; Milanesi O; Stellin G; Angelini A; Casarotto D
    Transplant Proc; 1998 Aug; 30(5):1975-6. PubMed ID: 9723358
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerability of mycophenolate mofetil in organ transplant recipients.
    Schweizer RT; Meisterling LD
    Transplant Proc; 2001 May; 33(3):2309. PubMed ID: 11377540
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine-induced hyperuricemia and gout in renal transplants.
    Ben Hmida M; Hachicha J; Bahloul Z; Kaddour N; Kharrat M; Jarraya F; Jarraya A
    Transplant Proc; 1995 Oct; 27(5):2722-4. PubMed ID: 7482890
    [No Abstract]   [Full Text] [Related]  

  • 20. Twelve years of cyclosporine in pediatric heart transplantation: what is the future?
    Parisi F; Abbattista AD; Squitieri C; Vinciguerra G; La Vigna G; Di Donato R; Catena G
    Transplant Proc; 1998 Aug; 30(5):1967-8. PubMed ID: 9723355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.